Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Investigational Alzheimer's Drugs for Early Onset Alzheimer's Disease
Recruiting0 awardsPhase 2 & 3
New Haven, Connecticut
This trial is testing if an investigational product can improve Alzheimer's disease-related biomarkers and slow the rate of progression of cognitive or clinical impairment.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.